Community Forum top_calendar.gif top_members.gif top_faq.gif top_search.gif top_home.gif    

Go Back   Community Forum > The Internet Medical Journal > News
User Name
Password
FAQ Members List Calendar Search Today's Posts Mark Forums Read


Reply
 
Thread Tools Search this Thread Display Modes
  #1  
Old July 4th, 2003, 06:28
sysadmin sysadmin is offline
Administrator
 
Join Date: 2001
Posts: 1,085
PET in the Detection of Axillary Nodes in Early Breast Cancer

TITLE: Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer.

REF: Annals of Surgical Oncology 10:622-627 (2003) http://www.annalssurgicaloncology.o...stract/10/6/622

STUDY TYPE: prospective trial

PATIENTS: 32 patients in France with breast cancer and clinically negative axillary nodes. All patients received an FDG PET scan in addition to sentinal node biopsy and axillary dissection.

FINDINGS: The sentinal node was positive in 14/32 patients (43%) and falsely negative in 1/15 (6.6%). PET was positive in 3/14 (20%) patients with positive sentinal nodes. PET sensitivity was 20%, specificity was 100%, and positive predictive value was 100%.

CONCLUSION: in patients with a positive FDG PET scan of the axilla, sentinal node biopsy can be skipped and axillary node dissection be the primary procedure.

COMMENT: these are fragile statistics but point out that a negative PET scan in this situation is pretty useless. The real value is in the positive PET scan which would allow proceding directly to axillary dissection. In this small series of patients, PET would decrease the sentinal lymph node biopsy rate by 20% which seems to be of little clinical benefit. Neither PET nor SLN biopsy caught all positive nodes.
Reply With Quote
  #2  
Old September 29th, 2004, 18:28
hudunnit hudunnit is offline
Registered User
 
Join Date: 2004
Posts: 3
Question Re: PET in the Detection of Axillary Nodes in Early Breast Cancer

I've read many abstracts and authoritative reports on PET for breast scanning.
My question is -- was it in 2001 and is it now - still investigational - requiring informed consent to participate in a clinical trial prior to a patient undergoing a nuclear diagnostic breast scan?

My information reveals it is "investigational to date"

Comments are really appreciated.
Reply With Quote
Reply


Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is On
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Detection of Early Recurrence with 18F-FDG PET in Patients with Cervical Cancer sysadmin News 0 March 31st, 2003 09:05
Guidelines for the Early Detection of Cancer sysadmin Guidelines for the Early Detection of Cancer 0 December 15th, 2002 13:08
August 2002 sysadmin News 0 September 2nd, 2002 19:44
July 2002 sysadmin News 0 August 12th, 2002 19:08
Meta-analysis: Mycobacterium avium subsp. paratuberculos in Crohn's Disease sysadmin Articles 0 September 24th, 2001 14:48


All times are GMT -8. The time now is 15:52.


Powered by: vBulletin Version 3.0.3
Copyright ©2000 - 2018, Jelsoft Enterprises Ltd.



Be careful about reading health books. You may die of a misprint.  
- Mark Twain (1835 - 1910)

We are committed to your good health. That means that while we provide editorial medical information, we must insist that you work with your own doctor in regards to your personal health issues. All content on Medjournal.Com is strictly editorial. It constitutes medical opinion, NOT ADVICE. We do not endorse or recommend the content of Medjournal.com or the sites that are linked FROM or TO Medjournal.com. Use common sense by consulting with your doctor before making any lifestyle changes or other medical decisions based on the content of these web pages. Medjournal.Com and the Internet Medical Journal shall not be held liable for any errors in content, advertising, or for any actions taken in reliance thereon.